Tuesday, 02 January 2024 12:17 GMT

New Swiss Study Explores Obesity And Metabolic Disease Link


(MENAFN- Swissinfo) Researchers in Zurich have mapped cellular changes in overweight individuals, which could shed light on the LINK between obesity and certain metabolic diseases.

This content was published on February 5, 2025 - 16:39 2 minutes Keystone-SDA
  • Deutsch de Zürcher Forschungsteam kartiert Zellen von Übergewichtigen Original Read more: Zürcher Forschungsteam kartiert Zellen von Übergewichtige

+ Get the most important news from Switzerland in your inbox

A research team in Zurich has developed a detailed map of cellular changes in overweight individuals. The federal technology institute ETH Zurich says this tool could help explain why some overweight people develop illnesses while others remain healthy.

+ Rising Swiss obesity levels: can new fat loss drugs like Ozempic and Wegovy help?

People who are significantly overweight face a higher risk of diabetes, high blood pressure and high cholesterol. However, not all overweight individuals develop these metabolic diseases, according to a press release from ETH Zurich on Wednesday. About a quarter of severely overweight people remain healthy.

To identify biological markers that raise the risk of metabolic diseases, ETH Zurich researchers, in collaboration with scientists from the University of Leipzig, Germany, collected cells from overweight individuals.

More More Roche's big bet on big diseases

This content was published on Oct 20, 2024 Swiss pharma giant Roche is the latest company to refocus its R&D investment on diseases like obesity that weigh heavily on healthcare budgets.

Read more: Roche's big bet on big disease

They also discovered differences between the cells of men and women. A specific type of progenitor cell is found only in the visceral fat of women. According to the researchers, this could explain why men and women develop metabolic diseases differently.

Translated from German with DeepL/sp

MENAFN06022025000210011054ID1109174444


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.